TBC1D8 Antibodies

Santa Cruz Biotechnology delivers a wide array of TBC1D8 monoclonal antibodies for research focused on understanding TBC1D8's role in cellular processes. TBC1D8 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TBC1D8 belongs to the TBC (Tre-2/Bub2/CDC16) domain family, which plays a significant role in regulating intracellular trafficking and membrane dynamics. TBC1D8 participates in modulating small GTPases, influencing essential processes such as endocytosis and exocytosis that maintain cellular homeostasis. Research has shown that TBC1D8 may have important implications in various diseases, including cancer and metabolic disorders. Investigating TBC1D8 function continues to reveal new insights into cellular regulation and disease mechanisms. Understanding TBC1D8's molecular interactions helps identify potential therapeutic targets. Exploring TBC1D8's role in different cellular pathways advances knowledge of disease progression. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of TBC1D8 and its impact on human health.